ArticleJournal of experimental & clinical cancer research : CR2020

Retraction Note: Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis.

Jialiang Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.